Comerica Bank’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-317
Closed -$1.81K 3718
2025
Q1
$1.81K Buy
317
+314
+10,467% +$3.2K ﹤0.01% 3496
2024
Q4
$29 Sell
3
-27
-90% -$231 ﹤0.01% 3662
2024
Q3
$245 Sell
30
-186
-86% -$1.86K ﹤0.01% 3638
2024
Q2
$2.89K Sell
216
-605
-74% -$18.1K ﹤0.01% 3411
2024
Q1
$38.1K Buy
821
+50
+6% +$2.59K ﹤0.01% 2835
2023
Q4
$52.1K Buy
771
+44
+6% +$2.69K ﹤0.01% 2710
2023
Q3
$52.6K Buy
+727
New +$58.1K ﹤0.01% 2694

Other funds holding DNA

Comerica Bank's DNA Position: Q2 2025 in Review

Comerica Bank sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 317 shares — an estimated $1.81K sold.

Comerica Bank first reported a position in DNA in Q3 2023 and held it in 7 quarters. The position peaked at $52.6K in Q3 2023. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Comerica Bank reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 317 Ginkgo Bioworks shares in Q2 2025, an estimated $1.81K.
  • Comerica Bank first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 7 quarters.
  • Comerica Bank's Ginkgo Bioworks position peaked at $52.6K in Q3 2023.
  • 166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.